|
|
Volumn 13, Issue 8, 2004, Pages 1071-1074
|
|
Strategic Research Institute G-protein-coupled receptors drug discovery world summit
|
|
Author keywords
G protein; GPCR; Lead generation; Medicinal chemistry; Receptor
|
|
Indexed keywords
ADENOSINE A1 RECEPTOR;
ADENOSINE A1 RECEPTOR AGONIST;
AVE 1734;
AVE 5997;
BETA GALACTOSIDASE;
BETA LACTAMASE;
CANNABINOID 1 RECEPTOR;
CANNABINOID 2 RECEPTOR;
CANNABINOID RECEPTOR AFFECTING AGENT;
CYCLIC AMP RECEPTOR;
DOPAMINE 2 RECEPTOR;
DOPAMINE 3 RECEPTOR BLOCKING AGENT;
EGLUMETAD;
G PROTEIN COUPLED RECEPTOR;
GLUTAMATE RECEPTOR 2;
GLUTAMATE RECEPTOR AGONIST;
INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR;
LY 566332;
LY 593093;
MUSCARINIC M1 RECEPTOR;
MUSCARINIC M4 RECEPTOR;
NOCICEPTIN RECEPTOR;
NOCICEPTIN RECEPTOR ANTAGONIST;
RACLOPRIDE;
SEROTONIN 1A AGONIST;
SEROTONIN 2 ANTAGONIST;
SEROTONIN 2A RECEPTOR;
SEROTONIN 2B RECEPTOR;
SEROTONIN 4 AGONIST;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ALZHEIMER DISEASE;
ANXIETY DISORDER;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONFERENCE PAPER;
DRUG BINDING SITE;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG RECEPTOR BINDING;
DRUG RESEARCH;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG TARGETING;
FLOW CYTOMETRY;
HUMAN;
LIGAND BINDING;
MOLECULAR MODEL;
NONHUMAN;
PROTEIN STRUCTURE;
PSYCHOSIS;
RECEPTOR AFFINITY;
RECEPTOR OCCUPANCY;
RECEPTOR SENSITIVITY;
VALIDATION PROCESS;
ANIMALS;
CHEMISTRY, PHARMACEUTICAL;
DRUG DESIGN;
DRUGS, INVESTIGATIONAL;
HUMANS;
MICE;
MOLECULAR MECHANISMS OF ACTION;
RECEPTORS, G-PROTEIN-COUPLED;
|
|
EID: 4344586340
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.13.8.1071 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
